This study demonstrates that the use of allogeneic stem cells derived from adipose tissue, combined with vitamin D, is associated with transient side effects, improved glycemic control, and a significant reduction in insulin requirements in newly diagnosed T1D patients. This evidence concerns the gene INS and type 1 diabetes mellitus.